Mirador Therapeutics, Inc.
Mirador Therapeutics, Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants | Healthy Volunteer | Recruiting | Phase 1 | 2026-08-21 | NCT07776782 | |
| A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-03-12 | NCT07113522 | |
| A First-in-Human Single and Multiple Ascending Dose Study of MT-251 | Healthy Volunteers | Recruiting | Phase 1 | 2026-02-25 | NCT07423299 | |
| A First-in-Human Single and Multiple Ascending Dose Study of MT-201 | Healthy Volunteer | Recruiting | Phase 1 | 2025-11-04 | NCT07219368 |